Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestMortgage LoansNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - DoubtfulReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WORK Medical Technology (WOK) Raw Materials (2023 - 2025)

WORK Medical Technology (WOK) posted Raw Materials of $527252.0 for Q3 2025, down 12.87% on a QoQ basis from $605154.0 in Q3 2024, and down 12.87% year-over-year from $605154.0 in Q3 2024.

WORK Medical Technology (WOK) has 3 years of Raw Materials data on file, last reported at $527252.0 in Q3 2025.

  • In Q3 2025, Raw Materials fell 12.87% year-over-year to $527252.0; the TTM figure through Sep 2025 stood at $527252.0 (down 12.87% YoY), while the FY2025 annual figure was $527252.0, down 12.87% from the prior year.
  • Raw Materials retreated to $527252.0 in Q3 2025, from $605154.0 in the prior quarter.
  • Across five years, Raw Materials topped out at $741988.0 in Q3 2023 and bottomed at $527252.0 in Q3 2025.
  • A 3-year average of $624798.0 and a median of $605154.0 in 2024 frame the typical range for Raw Materials.
  • Annual changes were most pronounced in 2024 — Raw Materials retreated 18.44% — and 2025, when it slipped 12.87%.
  • Year by year, Raw Materials stood at $741988.0 in 2023, then fell by 18.44% to $605154.0 in 2024, then slipped by 12.87% to $527252.0 in 2025.
  • The last three Raw Materials figures came in at $527252.0 (Q3 2025), $605154.0 (Q3 2024), and $741988.0 (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 WORK Medical Technology - - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 527,252.00
Sep 30, 2024 605,154.00
Sep 30, 2023 741,988.00